Analysts expect Zevra Therapeutics, Inc. to report revenue of 37.86 M for Q4 26, against a range of 34.61 M to 41.11 M. The most recent reported quarter, Q3 26, came in at 37.76 M, a 2.8% miss against the 38.85 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 12.00 M | 20.40 M | 25.88 M | 26.06 M | 34.10 M | 36.22 M | 39.66 M | 37.76 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 9.21 M | 17.23 M | 22.61 M | 30.48 M | 29.12 M | 36.57 M | 34.55 M | 41.43 M | 41.11 M | 47.21 M | 45.99 M | 47.03 M | 64.89 M | 52.14 M | 51.24 M | 50.27 M | |||||||||
| Low Estimate | 8.18 M | 15.45 M | 19.74 M | 25.85 M | 24.59 M | 30.89 M | 31.23 M | 36.27 M | 34.61 M | 40.48 M | 38.09 M | 40.33 M | 53.49 M | 46.72 M | 48.16 M | 47.30 M | |||||||||
| Consensus Estimate | 8.70 M | 16.34 M | 21.18 M | 28.17 M | 26.86 M | 33.73 M | 32.89 M | 38.85 M | 37.86 M | 43.84 M | 42.04 M | 43.68 M | 59.19 M | 49.43 M | 49.70 M | 48.79 M |
Analysts expect Zevra Therapeutics, Inc. to report earnings per share of 0.17 for Q4 26, against a range of 0.16 to 0.18. The most recent reported quarter, Q3 26, came in at 0.26, a 73.3% beat against the 0.15 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.67 | -0.06 | 1.21 | -0.01 | 0.19 | 0.60 | 0.14 | 0.26 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.36 | -0.18 | 2.59 | -0.03 | 0.05 | 0.09 | 0.11 | 0.16 | 0.18 | 0.24 | 0.30 | 0.30 | 0.32 | 0.44 | 0.40 | 0.23 | |||||||||
| Low Estimate | -0.40 | -0.20 | 2.17 | -0.03 | 0.05 | 0.07 | 0.09 | 0.14 | 0.16 | 0.22 | 0.28 | 0.26 | 0.28 | 0.40 | 0.34 | 0.19 | |||||||||
| Consensus Estimate | -0.38 | -0.19 | 2.38 | -0.03 | 0.05 | 0.08 | 0.10 | 0.15 | 0.17 | 0.23 | 0.29 | 0.28 | 0.30 | 0.42 | 0.37 | 0.21 |
Pull Wall Street consensus for Zevra Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ZVRA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ZVRA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ZVRA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();